Daily Stock Setups

JAZZ, ARRS, CYTR, ATPG, LINTA and CHRS Receiving Professional Financial Coverage from RothmanResearch.com

Posted on: Tue, 10 Nov 2009 06:55:00 EST

Symbols: JAZZ

Do you know when to trade JAZZ ?

Check for a PowerRating from TradingMarkets

NEW DELHI, INDIA, Nov 10, 2009 (MARKETWIRE via COMTEX) --
JAZZ | Quote | Chart | News | PowerRating -- RothmanResearch.com, www.rothmanresearch.com, is a unique and free
to use financial portal reaching all investors to provide the best
source of content and research they can find online. On this day, we
have begun tracking the following companies as they have shown
remarkable correction in recent days, you can access these free
reports with a number of other reviews by signing up for your
complimentary membership at : http://www.rothmanresearch.com/

Companies been researched today are:

Jazz Pharmaceuticals Inc. (NASDAQ: JAZZ | Quote | Chart | News | PowerRating) - Sector: Healthcare

Arris Group Inc. (NASDAQ: ARRS) - Sector: Technology

CytRx Corporation (NASDAQ: CYTR) - Sector: Healthcare

ATP Oil & Gas Corp. (NASDAQ: ATPG) - Sector: Basic Materials

Liberty Media Interactive (NASDAQ: LINTA) - Sector: Services

Charming Shoppes Inc. (NASDAQ: CHRS) - Sector: Services

At Rothman Research we have the fastest accurate system for locating,
analyzing, and reporting, which allows us to rapidly provide you with
all the information you need to make a sound investment decision. On
top of this we have a golden rule and we believe you will agree that
Knowledge is free and should accessible to everybody.

Take the time to register with us at http://www.rothmanresearch.com/

We want you to be part of our community for two simple reasons - we
offer you free dedicated services and we make it worthwhile for you to
be here because we care about your investment. We at
www.rothmanresearch.com believe that timing and awareness are key
components of every thriving investment, and thus we only release
analysis when the timing is ideal for action.

Our services encompass:


--  Free Corporate, Financial & Technical Analysis
--  Due-diligence and opinions are provided by trained CFAs
--  Free Portfolio Review

If you are an investor and have been trying to get quality for your
money, why spend your green when you can get it free at
www.rothmanresearch.com. If you are weary of being the last to hear
about stirring opportunities and want to know what the others seem to
know before you, sign up now for a lifetime free membership at
http://www.rothmanresearch.com/index.php?id=6&name=Register.

RothmanResearch.com has not been compensated by any of the above
mentioned companies. We act as an independent research portal and are
aware that all investment entails inherent risks.

SOURCE: Rothman Research

For full details on Jazz Pharmaceuticals Inc (JAZZ) JAZZ. Jazz Pharmaceuticals Inc (JAZZ) has Short Term PowerRatings at TradingMarkets. Details on Jazz Pharmaceuticals Inc (JAZZ) Short Term PowerRatings is available at This Link.

More News: Market Updates | Stock Alerts | All Trading News

Disclaimer:

The Connors Group, Inc. ("Company") is not an investment advisory service, nor a registered investment advisor or broker-dealer and does not purport to tell or suggest which securities or currencies customers should buy or sell for themselves. The analysts and employees or affiliates of Company may hold positions in the stocks, currencies or industries discussed here. You understand and acknowledge that there is a very high degree of risk involved in trading securities and/or currencies. The Company, the authors, the publisher, and all affiliates of Company assume no responsibility or liability for your trading and investment results. Factual statements on the Company's website, or in its publications, are made as of the date stated and are subject to change without notice.

It should not be assumed that the methods, techniques, or indicators presented in these products will be profitable or that they will not result in losses. Past results of any individual trader or trading system published by Company are not indicative of future returns by that trader or system, and are not indicative of future returns which be realized by you. In addition, the indicators, strategies, columns, articles and all other features of Company's products (collectively, the "Information") are provided for informational and educational purposes only and should not be construed as investment advice. Examples presented on Company's website are for educational purposes only. Such set-ups are not solicitations of any order to buy or sell. Accordingly, you should not rely solely on the Information in making any investment. Rather, you should use the Information only as a starting point for doing additional independent research in order to allow you to form your own opinion regarding investments. You should always check with your licensed financial advisor and tax advisor to determine the suitability of any investment.

HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN INHERENT LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING AND MAY NOT BE IMPACTED BY BROKERAGE AND OTHER SLIPPAGE FEES. ALSO, SINCE THE TRADES HAVE NOT ACTUALLY BEEN EXECUTED, THE RESULTS MAY HAVE UNDER- OR OVER-COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFITS OR LOSSES SIMILAR TO THOSE SHOWN.

The Connors Group, Inc.
10 Exchange Place, Suite 1800
Jersey City, NJ 07302

All analyst commentary provided on TradingMarkets.com is provided for educational purposes only. The analysts and employees or affiliates of TradingMarkets.com may hold positions in the stocks or industries discussed here. This information is NOT a recommendation or solicitation to buy or sell any securities. Your use of this and all information contained on TradingMarkets.com is governed by the Terms and Conditions of Use. Please click the link to view those terms. Follow this link to read our Editorial Policy.